FOXM1 and non-small cell lung carcinoma: FOXM1 has been previously identified as an essential molecular marker of NSCLC prognosis, because its expression is closely correlated with lymph node status and TNM stage, giving proliferation and invasion advantages to NSCLC cells [29].